Informazioni cliniche
Negli ultimi anni si è osservata la diffusione globale nuovi virus e agenti patogeni. Le malattie associate sono definite “malattie infettive emergenti”. Questo termine si riferisce a malattie infettive che si manifestano per la prima volta in una popolazione o che sono aumentate rapidamente in termini di incidenza o distribuzione regionale. I virus trasmessi dagli artropodi, noti anche come arbovirus, sono tra gli agenti causali più comuni di malattie nell'uomo in tutto il mondo e rappresentano un problema crescente degli ultimi decenni. Gli arbovirus hanno una grande capacità di mutare e adattarsi, motivo per cui spesso causano epidemie. Esempi importanti sono il Dengue, il Chikungunya e lo Zika, che si è diffuso in gran parte del Sud America nel 2015/2016. Tuttavia, anche in climi temperati, come in Europa, gli arbovirus come il West Nile e il Chikungunya hanno causato in passato epidemie stagionali. I decorsi clinici delle malattie causate dagli arbovirus sono molto simili, per cui la diagnosi non può basarsi solo sul quadro clinico.
Oltre ai già citati arbovirus, esistono diversi altri agenti patogeni che causano grandi epidemie e potrebbero trasformarsi in un significativo problema di salute globale, come la SARS-CoV-2, che ha causato una pandemia.
Diagnostica
La diagnosi di queste malattie è particolarmente complessa, poiché spesso non sono disponibili sistemi di test diagnostici commerciali per i parametri corrispondenti. In genere, l'infezione da un agente patogeno di una malattia emergente viene diagnosticata in base a criteri clinici, epidemiologici e a risultati di laboratorio. La diagnostica di laboratorio utilizza metodi di rilevamento diretti e indiretti ed è particolarmente importante per testare i pazienti dopo viaggi in aree endemiche e per lo screening di ampi gruppi di popolazione nel caso di un'epidemia o di una pandemia.
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | 5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2661-9601-2L G |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2661-9601-2L M | |
| IIFT | West Nile virus (WNV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2662-1005 G FI 2662-1005 M FI 2662-1010 G FI 2662-1010 M |
|
| IIFT | Japanese encephalitis virus (JEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM |
10 x 05 10 x 05 |
FI 2663-1005 G FI 2663-1005 M |
|
| IIFT | Yellow fever virus (YFV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2665-1005 G FI 2665-1005 M FI 2665-1010 G FI 2665-1010 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 266a-1005-1 G FI 266a-1005-1 M FI 266a-1010-1 G FI 266a-1010-1 M FI 266a-2005-1 G FI 266a-2005-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 277a-1005-1 G FI 277a-1005-1 M FI 277a-1010-1 G FI 277a-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 1 types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-1 G FI 278h-1005-1 M FI 278h-1010-1 G FI 278h-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 2 Eurasia types Hantaan (HTNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected and non- infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-2 G FI 278h-1005-2 M FI 278h-1010-2 G FI 278h-1010-2 M |
|
| IIFT |
Hantavirus Mosaic 3: America types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 278m-1005-3 G FI 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 293a-1005 G FI 293a-1005 M FI 293a-1010 G FI 293a-1010 M FI 293a-2005 G FI 293a-2005 M |
|
| IIFT |
Arbovirus Fever Mosaic 1 Chikungunya virus (CHIKV) Japanese encephalitis virus (JEV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 293a-1005-1 G FI 293a-1005-1 M FI 293a-1010-1 G FI 293a-1010-1 M |
|
| IIFT | Yellow fever virus (YFV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI |
10 x 05 10 x 05 |
FR 2665-1005 G FR 2665-1005 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) EUROPattern |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 266a-1005-1 G FR 266a-1005-1 M FR 266a-1010-1 G FR 266a-1010-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 EUROPattern types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 277a-1005-1 G FR 277a-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 1 EUROPattern types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278h-1005-1 G FR 278h-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 3: America EUROPattern types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278m-1005-3 G FR 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 293a-1005 G FR 293a-1005 M FR 293a-1010 G FR 293a-1010 M |
|
| ELISA |
Anti-West Nile Virus ELISA (IgG) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601 G |
| ELISA |
Anti-West Nile Virus ELISA (IgM) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2662-9601 M |
| ELISA |
Avidity: Anti-West Nile Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601-1 G |
| ELISA |
Anti-JEV ELISA (IgG) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2663-9601 G |
| ELISA |
Anti-JEV ELISA (IgM) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2663-9601 M |
| ELISA | Anti-Usutu Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant glycoprotein E of Usutu virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2667-9601 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgG) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 266a-9601-1 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgM) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
semi-quantitative | IgM |
96 x 01 |
EI 266a-9601-1 M |
| ELISA | Anti-Dengue Virus NS1 ELISA 2.0 (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Dengue virus |
IgG |
96 x 01 |
EI 266a-9601-3 G | |
| ELISA | Anti-Oropouche Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2771-9601 G |
| ELISA | Anti-Oropouche Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
semi-quantitative | IgM |
96 x 01 |
EI 2771-9601 M |
| ELISA | Anti-Toscana virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant N-protein from Toscana virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 277c-9601 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-1 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-1 M |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-2 G |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-2 M |
| ELISA | Anti-Chikungunya Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 293a-9601 G |
| ELISA | Anti-Chikungunya Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
semi-quantitative | IgM |
96 x 01 |
EI 293a-9601 M |
| ELISA | Anti-Mayaro Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 295c-9601 G |
| ELISA | Anti-Mayaro Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
semi-quantitative | IgM |
96 x 01 |
EI 295c-9601 M |
| ELISA |
Dengue virus NS1 antigen detection (DENV) |
antibody-coated microplate wells |
Dengue virus NS1 (type 1-4) | 1/10/100 RU/ml |
96 x 01 |
EQ 266a-9601-1 | |
| IIFT | Zika virus (ZIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005 G FI 2668-1005 M FI 2668-1010 G FI 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005-1 G FI 2668-1005-1 M FI 2668-1010-1 G FI 2668-1010-1 M |
|
| IIFT |
Arbovirus Profile 3 upper row : Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) bottom row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
infected cells infected cells infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 2668-1005-3 G FI 2668-1005-3 M |
|
| IIFT | Zika virus (ZIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005 G FR 2668-1005 M FR 2668-1010 G FR 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 EUROPattern Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005-1 G FR 2668-1005-1 M FR 2668-1010-1 G FR 2668-1010-1 M |
|
| ELISA | Anti-Zika Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2668-9601 G |
| ELISA | Anti-Zika Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
semi-quantitative | IgM |
96 x 01 |
EI 2668-9601 M |
| ELISA | Anti-Zika Virus ELISA (IgAM) |
antigen-coated microplate wells |
specific NS1 antigen from Zika virus |
semi-quantitative | IgAM |
96 x 01 |
EI 2668-9601 Q |
| ELISA |
Anti-MERS-CoV ELISA (IgG) Middle east respiratory syndrome coronavirus |
antigen-coated microplate wells |
recombinant S1 antigen of MERS coronavirus (MERS-CoV S1) |
semi-quantitative | IgG |
96 x 01 |
EI 2604-9601 G |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgA) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgA |
96 x 01 |
EI 2606-9601 A |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601 G |
| ELISA |
Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
1/10/20/40/80/120 RU/mL | IgG |
96 x 01 |
EI 2606-9601-10 G | ||
| ELISA |
Anti-SARS-CoV-2 NCP ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 nucleocapsid protein |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601-2 G | ||
| ChLIA | Anti-SARS-CoV-2 RBD ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LI 2606-10010-1 G | |
| ChLIA | Control set Anti-SARS-CoV-2 RBD ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2606-20210-1 G | ||
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgG) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 279a-9601 G |
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgM) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
semi-quantitative | IgM |
96 x 01 |
EI 279a-9601 M |
| IIFT | TBE virus (TBEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005 G FI 2661-1005 M FI 2661-1010 G FI 2661-1010 M |
|
| IIFT |
Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005-1 G FI 2661-1005-1 M FI 2661-1010-1 G FI 2661-1010-1 M |
|
| IIFT |
Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2661-1005-2 G FI 2661-1005-2 M FI 2661-2005-2 G FI 2661-2005-2 M |
|
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgG |
96 x 01 |
EI 2661-9601-2 G | |
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
semi-quantitative | IgM |
96 x 01 |
EI 2661-9601-2 M | |
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||